OncoCyte Debt to Equity Ratio 2014-2024 | OCX

Current and historical debt to equity ratio values for OncoCyte (OCX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. OncoCyte debt/equity for the three months ending March 31, 2024 was 0.00.
OncoCyte Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.06B $0.01B 5.13
2023-12-31 $0.05B $0.02B 2.66
2023-09-30 $0.04B $0.04B 1.17
2023-06-30 $0.04B $0.04B 1.01
2023-03-31 $0.05B $0.04B 1.18
2022-12-31 $0.07B $0.03B 1.92
2022-09-30 $0.08B $0.08B 1.05
2022-06-30 $0.09B $0.08B 1.06
2022-03-31 $0.09B $0.06B 1.57
2021-12-31 $0.09B $0.07B 1.45
2021-09-30 $0.07B $0.10B 0.69
2021-06-30 $0.08B $0.10B 0.73
2021-03-31 $0.02B $0.11B 0.21
2020-12-31 $0.02B $0.03B 0.66
2020-09-30 $0.02B $0.04B 0.67
2020-06-30 $0.02B $0.04B 0.60
2020-03-31 $0.02B $0.04B 0.63
2019-12-31 $0.01B $0.03B 0.29
2019-09-30 $0.00B $0.03B 0.12
2019-06-30 $0.00B $0.03B 0.12
2019-03-31 $0.00B $0.04B 0.09
2018-12-31 $0.01B $0.00B 1.78
2018-09-30 $0.01B $0.01B 0.72
2018-06-30 $0.01B $0.01B 0.78
2018-03-31 $0.01B $0.01B 0.73
2017-12-31 $0.01B $0.00B 1.32
2017-09-30 $0.01B $0.01B 0.77
2017-06-30 $0.01B $0.01B 1.15
2017-03-31 $0.01B $0.01B 0.73
2016-12-31 $0.01B $0.01B 0.47
2016-09-30 $0.00B $0.01B 0.33
2016-06-30 $0.00B $0.00B 0.66
2016-03-31 $0.00B $0.01B 0.40
2015-12-31 $0.00B $0.01B 0.22
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.01B $-0.00B -5.90
2013-12-31 $0.01B $0.00B 1.29
Sector Industry Market Cap Revenue
Medical Medical Services $0.027B $0.002B
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $116.504B 14.20
Cencora (COR) United States $44.729B 17.44
ICON (ICLR) Ireland $27.407B 25.88
DiDi Global (DIDIY) China $17.692B 0.00
CochLear (CHEOY) Australia $14.645B 0.00
Avantor (AVTR) United States $14.380B 21.17
Viatris (VTRS) United States $13.693B 4.09
Revvity (RVTY) United States $13.578B 23.82
Natera (NTRA) United States $13.081B 0.00
Charles River Laboratories (CRL) United States $11.347B 21.72
Medpace Holdings (MEDP) United States $11.070B 33.61
EUROFINS SCIENT (ERFSF) Luxembourg $9.854B 0.00
Solventum (SOLV) United States $9.782B 0.00
Sonic Healthcare (SKHHY) Australia $8.268B 0.00
HealthEquity (HQY) United States $6.856B 44.02
Bausch + Lomb (BLCO) Canada $5.992B 23.99
Organon (OGN) United States $5.519B 5.23
Doximity (DOCS) United States $5.235B 36.66
PACS (PACS) United States $5.163B 0.00
Life Times (LTH) United States $4.191B 43.92
Sotera Health (SHC) United States $3.773B 18.51
Surgery Partners (SGRY) United States $3.602B 32.95
GoodRx Holdings (GDRX) United States $3.343B 127.29
Agilon Health (AGL) United States $2.904B 0.00
Progyny (PGNY) United States $2.691B 46.33
AMN Healthcare Services Inc (AMN) United States $2.272B 9.00
BrightSpring Health Services (BTSG) United States $2.085B 0.00
Premier (PINC) United States $2.083B 8.91
Alignment Healthcare (ALHC) United States $1.824B 0.00
Teladoc Health (TDOC) United States $1.577B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.467B 0.00
Establishment Labs Holdings (ESTA) $1.321B 0.00
CareDx (CDNA) United States $0.990B 0.00
Embecta (EMBC) United States $0.935B 6.36
GeneDx Holdings (WGS) United States $0.869B 0.00
InnovAge Holding (INNV) United States $0.840B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Auna S.A (AUNA) Luxembourg $0.638B 0.00
Sharecare (SHCR) United States $0.500B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.497B 0.00
Enhabit (EHAB) United States $0.488B 48.65
Sonida Senior Living (SNDA) United States $0.420B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
DocGo (DCGO) United States $0.337B 18.44
ModivCare (MODV) United States $0.337B 6.30
LifeMD (LFMD) United States $0.292B 0.00
MultiPlan (MPLN) United States $0.289B 0.00
Sera Prognostics (SERA) United States $0.260B 0.00
Beauty Health (SKIN) United States $0.230B 0.00
Ascend Wellness Holdings (AAWH) United States $0.206B 0.00
Biodesix (BDSX) United States $0.189B 0.00
So-Young (SY) China $0.098B 47.50
Pono Capital Two (PTWO) United States $0.072B 0.00
NeueHealth (NEUE) United States $0.044B 5.88
Oncology Institute (TOI) United States $0.041B 0.00
Co-Diagnostics (CODX) United States $0.041B 0.00
IceCure Medical (ICCM) Israel $0.038B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.018B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.003B 0.00
Assure Holdings (IONM) United States $0.001B 0.00